Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12 Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • Key Points Patients with relapsed or refractory transformed indolent lymphoma and DLBCL have similar outcomes with salvage therapy and ASCT. This therapy should be considered the standard of care for previously treated transformed indolent lymphoma.

authors

  • Kuruvilla, John
  • MacDonald, David A
  • Kouroukis, C Tom
  • Cheung, Matthew
  • Olney, Harold J
  • Turner, A Robert
  • Anglin, Peter
  • Seftel, Matthew
  • Ismail, Walid Sabry
  • Luminari, Stefano
  • Couban, Stephen
  • Baetz, Tara
  • Meyer, Ralph
  • Hay, Annette E
  • Shepherd, Lois
  • Djurfeldt, Marina S
  • Alamoudi, Sameer
  • Chen, Bingshu E
  • Crump, Michael

publication date

  • August 6, 2015

has subject area

published in